IRCT20151227025726N25尚未招募3 期
Evaluating the Efficacy of Melatonin in Sleep Disorders of Sarcoidosis Patients
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •Patients with age above 18 years with pulmonary sarcoidosis and sleep-related disorders (Pittsburgh Sleep Quality Index equal or greater than 5) that refer to the Sarcoidosis Clinic of Masih Daneshvari Hospital.
排除标准
- •Breastfeeding
- •Neurological disease (stroke, epilepsy, tumor, previously neurologic manipulation)
- •Use of any sedative or hypnotic drugs (anti histamine drugs, benzodiazepines)
- •Use of stimulant drugs
- •Allergy to melatonin or formulation components
- •Having parasomnia
- •Shift work sleep disorder
- •Fluvoxamine consumption
研究者
相似试验
招募中
3 期
The efficacy of melatonin for the prevention of taxane-induced peripheral neuropathyTaxane-induced peripheral neuropathy in patients with breast cancer.benign neoplasm of breastD24.9IRCT20160310026998N14Tabriz University of Medical Sciences132
已完成
3 期
The effect of melatonin on sleep disorders in children with cerebral palsyCondition 1: cerebral palsy. Condition 2: Sleep disorders.Spastic quadriplegic cerebral palsySleep disordersG80.0IRCT20191017045142N1Mashhad University of Medical Sciences50
已完成
不适用
Evaluation of melatonin therapy on sleep and delirium in intensive care patientservous System Diseases: Sleep disordersNervous System DiseasesSleep disordersISRCTN47578325Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)48
尚未招募
3 期
Evaluating the effect of melatonin compared to duloxetine in the treatment of chemotherapy-induced neuropathy (CINP): a clinical trialChemotherapy-induced neuropathy.Drug-induced polyneuropathyG62.0IRCT20211028052893N1Babol University of Medical Sciences60
招募中
3 期
Melatonin in COVID-19IRCT20200506047323N5Bandare-abbas University of Medical Sciences60